Phase II study of (90)y Ibritumomab Tiuxetan (Zevalin) in Patients with Previously Untreated Marginal Zone Lymphoma

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Fabregas, JC; Hoffman, JE; Koru-Sengul, T; Feng, M; Goodman, D; Serafini, A; Hosein, PJ; Stefanovic, A; Rosenblatt, JD; Lossos, IS

Published Date

  • December 6, 2014

Published In

Volume / Issue

  • 124 / 21

Published By

Pages

  • 4

Electronic International Standard Serial Number (EISSN)

  • 1528-0020

International Standard Serial Number (ISSN)

  • 0006-4971

Conference Name

  • 56th Annual Meeting of the American-Society-of-Hematology

Conference Location

  • San Francisco, CA

Conference Start Date

  • December 6, 2014

Conference End Date

  • December 9, 2014